论文部分内容阅读
目的观察厄贝沙坦治疗老年原发性高血压的的临床疗效。方法选择符合标准的老年原发性高血压患者80例,采取随机双盲对照试验的方法,将病例分成甲、乙两组,甲组40人,乙组40人,进行双盲治疗,两组用药顺序进行自身前后交叉。所有研究对象入组前停用其他降压药物5个半衰期,观察组用厄贝沙坦,150mg,口服,1次/日;对照组用尼群地平片,10mg,口服,3次/日;4周为1个疗程,且治疗期间禁用其他对血压有影响的药物。结果与结论厄贝沙坦组总有效率为93.75%,尼群地平组总有效率为83.25%。
Objective To observe the clinical efficacy of irbesartan in the treatment of senile essential hypertension. Methods A total of 80 elderly patients with essential hypertension were enrolled in this study. The patients were divided into two groups according to a randomized, double-blind controlled trial: 40 cases in group A and 40 cases in group B, Medication order to cross their own before and after. All subjects were stopped before the introduction of other antihypertensive drugs 5 half-lives, the observation group with irbesartan, 150mg, orally, 1 / day; the control group with nitrendipine tablets, 10mg, orally, 3 times / day; 4 weeks for a course of treatment, and disable the other during the treatment of blood pressure drugs. RESULTS AND CONCLUSION: The total effective rate was 93.75% in irbesartan group and 83.25% in nitrendipine group.